PERFORATING SCLERAL VESSELS IN HIGH MYOPIA: Overview of Imaging Features, Clinical Implications, and Future Directions

高度近视患者的巩膜穿孔血管:影像学特征、临床意义及未来方向概述

阅读:1

Abstract

PURPOSE: This review aims to consolidate current knowledge on the role of perforating scleral vessels (PSVs) in high myopia (HM), providing an updated overview of their clinical significance, imaging characteristics, and potential therapeutic implications. METHODS: Literature review up to July 2025. RESULTS: PSVs, originating from the short posterior ciliary arteries, penetrate the sclera and may contribute to biomechanical stress, ischemic alterations, and neovascular proliferation in highly myopic eyes. Increasing evidence suggests their complex role in the development and progression of myopic maculopathy, particularly in lacquer cracks, myopic choroidal neovascularizations, chorioretinal atrophy, and focal scleral ectasia. Advanced imaging techniques, such as enhanced depth imaging optical coherence tomography and swept-source OCT, have enabled better visualization of PSVs and their anatomical relationship with structural changes in highly myopic eyes. However, recent studies have revealed contradictory findings regarding PSVs' role in myopic choroidal neovascularization pathogenesis, with some studies suggesting a pathogenic association while others propose a protective effect. The relationship between PSVs and myopic choroidal neovascularization appears complex and context-dependent, potentially involving both mechanical stress mechanisms and hemodynamic factors. CONCLUSION: Despite their increasing recognition, the precise mechanisms by which PSVs influence myopic disease remain incompletely understood. Standardized quantification methods and prospective studies are needed to clarify their complex role in disease progression and to explore novel treatment strategies.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。